Regenerative Medical Solutions, Inc. advances regenerative medicine at the intersection of stem cell research, pancreatic islet biology, and islet transplantation. Operating from Madison, Wisconsin, and Chicago, Illinois, our privately owned team focuses on translating rigorous science into practical tools and pathways that can help improve patient outcomes. As a stem cell biotech company, we collaborate with leading academic groups and global life science partners to move promising concepts from the bench toward real-world impact. Our portfolio includes ILC Cell Kits, designed to support research workflows centered on islet lineage and cell characterization. We prioritize reliability, reproducibility, and clarity in every product and collaboration, helping labs streamline processes and gain confidence in their data. From protocol development to application-oriented resources, we are committed to fueling progress in regenerative medicine. Whether your work explores differentiation strategies, islet function, or transplantation models, our team brings a solution-driven mindset and a track record in entrepreneurship and product development to every partnership.

Website: https://www.regenmedsolutions.com/